Opening book details…
About this nonfiction
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET by Gennari, A. (author);Brain, E. (author);De Censi, A. (author);Nanni, O. (author);Wuerstlein, R. (author);Frassoldati, A. (author);Cortes, J. (author);Rossi, V. (author);Palleschi, M. (author);Alberini, J.L. (author);Matteucci, F. (author);Piccardo, A. (author);Sacchetti, G. (author);Ilhan, H. (author);D’Avanzo, F. (author);Ruffilli, B. (author);Nardin, S. (author);Monti, M. (author);Puntoni, M. (author);Fontana, V. (author);Boni, L. (author);Harbeck, N. (author);Malagutti, Bianca (author);Dib, Bassam (author);Branni, Carmen (author);D’Amico, Mauro (author);Provinciali, Nicoletta (author);Corradengo, Davide (author);Fiz, Francesco (author);Iacozzi, Massimiliano (author);Rocca, Andrea (author);Degenhardt, Tom (author);Vavasseur, Patrick (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Gennari, A. (author);Brain, E. (author);De Censi, A. (author);Nanni, O. (author);Wuerstlein, R. (author);Frassoldati, A. (author);Cortes, J. (author);Rossi, V. (author);Palleschi, M. (author);Alberini, J.L. (author);Matteucci, F. (author);Piccardo, A. (author);Sacchetti, G. (author);Ilhan, H. (author);D’Avanzo, F. (author);Ruffilli, B. (author);Nardin, S. (author);Monti, M. (author);Puntoni, M. (author);Fontana, V. (author);Boni, L. (author);Harbeck, N. (author);Malagutti, Bianca (author);Dib, Bassam (author);Branni, Carmen (author);D’Amico, Mauro (author);Provinciali, Nicoletta (author);Corradengo, Davide (author);Fiz, Francesco (author);Iacozzi, Massimiliano (author);Rocca, Andrea (author);Degenhardt, Tom (author);Vavasseur, Patrick (author)
- Publisher
- Elsevier BV
- Published
- 2024
- Language
- EN
- Category
- nonfiction
More by Gennari, A. (author);Brain, E. (author);De Censi, A. (author);Nanni, O. (author);Wuerstlein, R. (author);Frassoldati, A. (author);Cortes, J. (author);Rossi, V. (author);Palleschi, M. (author);Alberini, J.L. (author);Matteucci, F. (author);Piccardo, A. (author);Sacchetti, G. (author);Ilhan, H. (author);D’Avanzo, F. (author);Ruffilli, B. (author);Nardin, S. (author);Monti, M. (author);Puntoni, M. (author);Fontana, V. (author);Boni, L. (author);Harbeck, N. (author);Malagutti, Bianca (author);Dib, Bassam (author);Branni, Carmen (author);D’Amico, Mauro (author);Provinciali, Nicoletta (author);Corradengo, Davide (author);Fiz, Francesco (author);Iacozzi, Massimiliano (author);Rocca, Andrea (author);Degenhardt, Tom (author);Vavasseur, Patrick (author)
Similar books
- Tucatinib and Trastuzumab in HER2-mutated Metastatic Breast Cancer: a Phase 2 Basket Trial — Alicia F. C. Okines & Giuseppe Curigliano & Nobumasa Mizuno & Do-Youn Oh & Andree Rorive & Hatem Soliman & Shunji Takahashi & Tanios Bekaii-Saab & Mark E. Burkard & Ki Y. Chung & Philip R. Debruyne & Jenny R. Fox & Valentina Gambardella & Marta... (2025)
- Inhibition of Lysine Acetyltransferase KAT6 in ER+HER2- Metastatic Breast Cancer: a Phase 1 Trial — Toru Mukohara & Yeon Hee Park & David Sommerhalder & Kan Yonemori & Erika Hamilton & Sung-Bae Kim & Jee Hyun Kim & Hiroji Iwata & Toshinari Yamashita & Rachel M. Layman & Monica Mita & Timothy Clay & Yee Soo Chae & Catherine Oakman & Fengting Yan & Gun... (2024)
- Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry — Michael P. Lux, Naiba Nabieva, Andreas D. Hartkopf, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Matthias Geberth, Wolfgang Abenhardt, Christian Kurbacher, Rachel Wuerstlein, Christoph Thomssen, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Diethelm Wallwiener, Andreas Schneeweiss, Sara Y. Brucker (2019)
- Trastuzumab Deruxtecan in Metastatic Breast Cancer with Variable HER2 Expression: the Phase 2 DAISY Trial — Fernanda Mosele & Elise Deluche & Amelie Lusque & Loïc Le Bescond & Thomas Filleron & Yoann Pradat & Agnes Ducoulombier & Barbara Pistilli & Thomas Bachelot & Frederic Viret & Christelle Levy & Nicolas Signolle & Alexia Alfaro & Diep T. N. Tran &... (2023)
- Sacituzumab Govitecan in HR+HER2- Metastatic Breast Cancer: the Randomized Phase 3 EVER-132-002 Trial — Binghe Xu & Shusen Wang & Min Yan & Joohyuk Sohn & Wei Li & Jinhai Tang & Xiaojia Wang & Ying Wang & Seock-Ah Im & Dongdong Jiang & Theresa Valdez & Anandaroop Dasgupta & Yiran Zhang & Yilin Yan & Kimberly M. Komatsubara & Wei-Pang Chung & Fei Ma &... (2024)
- Ebastine Impairs Metastatic Spread in Triple-negative Breast Cancer by Targeting Focal Adhesion Kinase — Juyeon Seo & Minsu Park & Dongmi Ko & Seongjae Kim & Jung Min Park & Soeun Park & Kee Dal Nam & Lee Farrand & Jinsol Yang & Chaok Seok & Eunsun Jung & Yoon-Jae Kim & Ji Young Kim & Jae Hong Seo (2023)